DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $38

Needham maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $36 to $38.

Benzinga · 02/07/2020 11:48

Needham maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $36 to $38.